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1.	List	of	abbreviations	
AP2	 Adaptor	complex	2	 kb	 kilobase	
AP2M1	 Adaptor	related	protein	complex	2μ	1	 KIF11	 Kinesin	family	member	11	
ATP	 Adenosine	triphosphate	 KPNB1	 karyopherin	subunit	β	1	
ATP6V1B2	 ATPase	H+	transporting	V1	subunit	B2	 KREMEN2	 Kringle	containing	transmembrane	protein	2	
ATP6V1G1	 ATPase	H+	transporting	V1	subunit	G1	 MEM	 Minimum	Essential	Medium	
BSA	 Bovine	serum	albumin	 miRNA	 Micro-RNA	
CLTC	 Clathrin	heavy	chain	 mRNA	 Messenger	RNA	
CSPG5	 Chondroitin	sulfate	proteoglycan	5	 NRAMP2	 Natural	resistance	associated	macrophage	protein	2	
DDX	 DEAD-box	helicase	 nsP	 Non-structural	protein	
DHX	 DEAH-box	helicase	 PBS	 Phosphate-buffered	saline	
DMEM	 Dulbecco’s	Modified	Eagle’s	Medium	 PFA	 Para-formaldehyde	
DMN2	 Dynamin-2	 PHB2	 Prohibitin-2	
EDF1	 Endothelial	Differentiation	Related	Factor	1	 PM	 Plasma	membrane	
EIF2B3	 Eukaryotic	translation	initiation	factor	2B	subunit	γ	 PPBI	 Cyclophilin	B	(human)	
EIF4G1	 Eukaryotic	translation	initiation	factor	γ	1	 Ppbi	 Cyclophilin	B	(mouse)	
ESCRT	 Endosomal	sorting	complexes	required	for	transport	 PVR	 Polio	virus	receptor	
ETF1	 Eukaryotic	translation	termination	factor	1	 +RNA	 Positive-strand	RNA	
FBS	 Fetal	bovine	serum	 -RNA	 Negative-strand	RNA	
GABA	 γ-aminobutyric	acid	 RPL18	 Ribosomal	protein	L18	
GAT-2	 GABA	transporter	2	 RT	 Room	temperature	
GDP	 Guanosine	diphosphate	 SFV	 Semliki	Forest	virus	
GFP	 Green	fluorescent	protein	 siRNA	 Small	interfering	RNA	
GNPDA1	 Glucosamine-6-phosphate	deaminase	1	 SLC6	 Solute	carrier	family	6	
GTP	 Guanosine	triphosphate	 SLC6A13	 Solute	carrier	family	6	member	13	
HCV	 Hepatitis	C	virus	 TNP01	 Transportin-1	
HDAC	 Histone	deacetylase	 UPF1	 Regulator	of	nonsense	transcripts-1	
HDAC6	 Histone	deacetylase	6	 UTR	 Untranslated	region	
HIV-1	 Human	immunodeficiency	virus	1	 vATPase	 Vesicular	ATPase	
IAV	 Influenza	A	virus	 VSV	 Vesicular	stomatitis	virus			 	
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2.	Introduction		
2.1	Virus-host	interactions	As	obligate	parasites,	viruses	require	diverse	cellular	factors	for	the	completion	of	their	 life	cycles.	Viruses	use	host	 factors	to	bind	and	enter	cells	as	well	as	to	replicate	their	genomes	and	produce	new	virions.	On	the	other	hand,	a	number	of	host	proteins	work	to	counteract	viral	infection.		To	initiate	successful	 infection,	viruses	need	to	bind	to	the	surface	of	their	host	cells.	 In	animal	cells,	 this	process	 is	mediated	by	host’s	attachment	 factors	and	virus	receptors,	which	are	commonly	cells	surface	glycoproteins	and	glycolipids	(Smith	 &	 Helenius,	 2004).	 Attachment	 factors	 bind	 the	 virus	 on	 the	 plasma	membrane	 (PM)	 of	 the	 host,	 often	 via	 non-specific	 electrostatic	 interactions	(Grove	&	Marsh,	2011)	(Figure	1	A).	This	initial	binding	allows	the	bound	virion	to	recruit	the	receptor	molecules	that	initiate	the	entry	process	(Grove	&	Marsh,	2011)	(Figure	1	B).	Virus	entry	is	usually	mediated	by	endocytosis,	a	process	by	which	the	cell	is	able	to	internalize	portions	of	the	PM	and	extracellular	solutes,	such	as	nutrients	and	hormones	(Marsh	&	Helenius,	2006).	Multiple	endocytosis	mechanisms	 exist	 and	 they	 can	be	 roughly	divided	 to	 two	 categories	based	on	the	 volume	 of	 the	 endocytic	 vesicle	 and	 the	 mechanism	 of	 vesicle	 formation	(Doherty	 &	McMahon,	 2009).	 In	 “micropinocytosis”,	 such	 as	 clathrin-mediated	endocytosis,	the	vesicle	is	formed	by	invaginations	of	the	PM	and	small	volumes	of	 the	 extracellular	 medium	 are	 internalized	 (Doherty	 &	 McMahon,	 2009).	Macropinocytic	vesicles	are	the	result	of	PM	protrusions	that	“grab”	extracellular	medium	or	 even	 other	 cells	 (phagocytosis)	 and	 then	 fuse	 back	 to	 the	PM	with	their	 cargo	 (Doherty	&	McMahon,	 2009).	 Different	 viruses,	 such	 as	 hepatitis	 C	virus	 (HCV)	 (clathrin-mediated	 endocytosis)	 or	 Kaposi’s	 sarcoma-associated	herpesvirus	 (macropinocytosis)	 are	 able	 to	 exploit	 the	 full	 variety	 of	 these	processes	(Meertens	et	al,	2006;	Raghu	et	al,	2009;	Mercer	et	al,	2010).		Recruiting	 the	 endocytic	 machinery	 gives	 viruses	 multiple	 advantages	 over	penetrating	 the	 PM	 directly.	 Internalizing	 the	 entire	 virion	 prevents	 the	accumulation	of	potentially	antigenic	viral	components	on	the	host	surface,	gives	
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the	 virus	 a	 convenient	way	 to	 infiltrate	 deep	 into	 the	 cell,	 and	 gives	 the	 virus	access	 to	 intracellular	 compartments	where	 chemical	 cues	destabilize	 the	viral	particle	 and	 initiate	 the	 disassembly	 process	 known	 as	 uncoating	 (Marsh	 &	Helenius,	2006).	These	cues	are	either	changes	in	the	pH	of	the	endosome	or	the	action	 of	 endosomal	 enzymes	 (Grove	 &	 Marsh,	 2011).	 The	 conditions	 of	 the	endosome	 cause	 conformational	 changes	 in	 the	 viral	 fusion	 proteins,	 which	allows	 the	 virus	 to	 penetrate	 the	 endosomal	 membrane	 into	 the	 cytoplasm	(Grove	&	Marsh,	2011).	This	results	in	the	delivery	of	the	viral	nucleocapsid	into	the	site	of	uncoating	and/or	replication	(Grove	&	Marsh,	2011)	(Figure	1	D).			The	next	 step	 in	 the	viral	 life	 cycle	 is	 the	 transcription	and	 translation	of	 viral	messenger	RNAs	(mRNAs),	or	in	the	case	of	positive-strand	(+RNA)	viruses,	the	direct	 translation	 of	 the	 viral	 genome.	 RNA	 viruses	 use	 their	 own	 RNA-dependent	RNA	polymerases	 for	 transcription	but	 they	use	host	machinery	 for	translation,	 which	 leads	 to	 a	 translational	 competition	 between	 host	 and	 viral	RNAs	(Walsh	&	Mohr,	2011)	(Figure	1	E).	This	interaction	is	further	complicated	by	 host	 antiviral	 defenses	 that	 aim	 to	 shut	 down	 translation	 (Walsh	 &	 Mohr,	2011).	 Therefore	 it	 is	 understandable	 that	 viruses	 have	 evolved	 myriad	mechanisms	to	usurp	the	protein	synthesis	machinery	of	the	host	and	to	keep	it	operational	despite	host	antiviral	response	(Walsh	&	Mohr,	2011).		Once	 the	 cell	 is	 under	 viral	 control,	 the	 final	 stage	 of	 the	 infection	begins.	 The	viral	genome	is	replicated	and	progeny	virions	are	assembled	by	exploiting	host	resources	and	structures,	such	as	the	PM,	the	endoplasmic	reticulum,	or	the	Golgi	apparatus	(Kuismanen	et	al,	1982;	Gosert	et	al,	2003;	Spuul	et	al,	2010)	(Figure	1	E).	Once	the	new	generation	of	virions	 is	ready,	 they	exit	 the	cell	using	various	strategies.	 Viruses	may,	 for	 example,	 use	 the	 host’s	 ESCRT	 (endosomal	 sorting	complexes	 required	 for	 transport)	 system	 and	 bud	 from	 the	 PM	 (Votteler	 &	Sundquist,	2014),	use	an	exocytosis-like	pathway	 (Johnson	&	Baines,	2011),	or	cause	the	lysis	of	the	host	cell	(Tollefson	et	al,	1996)	(Figure	1	F).			As	virus	infection	is	highly	dependent	on	host	functions,	elucidating	the	interplay	between	 viral	 and	 cellular	 factors	 is	 crucial	 in	 understanding	 the	 biology	 of	
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viruses.	 Observing	 host-virus	 interactions	 also	 plays	 a	 key	 role	 in	 the	development	 of	 new	 treatments	 and	 therapies.	 In	 addition,	 by	 following	 the	different	 stages	 of	 virus	 infections,	 it	 is	 possible	 to	 assign	 novel	 functions	 to	poorly	characterized	cellular	factors.	
Figure	1.	The	 life	cycle	of	an	endocytosis-utilizing	enveloped	virus.	A:	The	virus	infection	begins	with	non-specific	binding	on	host	attachment	 factors	such	as	heparan	sulphate.	B:	Non-specific	binding	 leads	 to	receptor	recruitment	C:		Receptor	binding	is	often	multivalent	and	triggers	the	endocytosis	event.	D:	The	endosome	carries	the	virus	deeper	into	the	cell	using	 the	 tubular	network.	Endosomal	enzymes	and/or	 the	acidification	of	 the	endosome	by	the	action	of	host	vesicular	 ATPases	 (vATPases)	 leads	 to	 a	 conformational	 change	 in	 the	 viral	 spike	 proteins.	 This	 allows	 a	 membrane	fusion	event	to	occur,	which	releases	the	nucleocapsid	into	the	cytosol.		The	viral	genome	is	uncoated	and	transported	to	its	 replication	site.	E:	Viral	RNA	outcompetes	host	mRNA	by	 limiting	host	 transcription	or	preventing	host	 translation.	This	leads	to	the	production	of	viral	proteins	and	the	replication	of	the	viral	genome.	F:	The	viral	components	assemble	into	nucleocapsids,	which	exit	from	the	cells	e.g.	by	budding	from	the	PM.		
2.2	Semliki	Forest	virus	and	vesicular	stomatitis	virus	Semliki	 Forest	 virus	 (SFV)	 is	 one	 of	 the	 best-studied	 members	 of	 the	 genus	
Alphavirus.	 Like	 other	 alphaviruses,	 it	 is	 a	 +RNA	 virus	 that	 infects	 both	invertebrate	and	vertebrate	hosts	(Griffin,	2013).	SFV	virions	are	enveloped	and	have	a	diameter	of	70	nm,	with	icosahedrally	symmetric	nucleocapsids	(Mancini	
et	al,	2000).	SFV	enters	host	cells	using	endocytosis	and	penetrates	the	endocytic	vesicle	 after	 a	 low	 pH-induced	 conformational	 change	 in	 the	 SFV	 spike	glycoproteins	leads	to	the	fusion	of	viral	and	endosomal	membranes	(Helenius	et	
al,	 1980;	 White	 et	 al,	 1980;	 Fuller	 et	 al,	 1995).	 Once	 in	 the	 cytosol,	 the	nucleocapsid	 is	 immediately	 engaged	 by	 host	 ribosomes,	 which	 triggers	 the	
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uncoating	of	 the	nucleocapsid	and	 leads	 to	viral	 translation	 (Singh	&	Helenius,	1992).	The	 low	pH	of	 the	endosomes	 (<6.5)	 is	 crucial	 for	SFV	penetration,	and	treatments	 with	 small	 molecule	 inhibitors	 that	 neutralize	 endosomal	acidification	 block	 virus	 penetration	 and	 infection	 (Helenius	 et	 al,	 1980).	 The	role	 of	 endosomal	 acidification	 in	 SFV	 infection	 has	 been	 confirmed	 by	 small	interfering	 RNA	 (siRNA)-mediated	 depletions	 of	 different	 subunits	 of	 the	 host	vacuolar	ATPase	(vATPase),	a	membrane	pump	responsible	for	the	acidification	of	the	endosomes	(Balistreri	et	al,	2014).		The	 SFV	 genome	 is	 approximately	 11.5	 kilobases	 (kb)	 long	 and	 contains	 two	open	 reading	 frames	 and	 3’	 and	 5’	 untranslated	 regions	 (UTR)	 (European	Nucleotide	Archive,	 http://www.ebi.ac.uk/ena/data/view/X04129,	 Leinonen	et	
al,	 2011).	 The	 early	 genes	 of	 the	 SFV	 genome	 are	 translated	 directly	 from	 the	genome,	which	 is	 later	 replicated	 via	 a	 -RNA	 intermediate	 that	 is	 also	 used	 to	produce	 subgenomic	 RNA,	 which	 is	 translated	 to	 the	 structural	 genes	 (Kuhn,	2013).	Like	with	other	alphaviruses,	SFV	infection	results	in	a	global	inhibition	of	host	 transcription	 and	 translation	 (Fros	 &	 Pijlman,	 2016).	 The	 viral	 non-structural	protein	(nsP)	2	seems	to	play	an	important	role	in	this	process	(Fros	&	Pijlman,	2016).	To	counteract	the	host’s	antiviral	defense,	the	SFV	sub-genomic	RNA	contains	a	5’	hairpin	loop	that	allows	translation	of	SFV	capsid	and	envelope	proteins	 even	 when	 cap-dependent	 translation	 is	 inhibited	 due	 to	 the	 host-induced	phosphorylation	of	the	translation	factor	eIF2α	(Fros	&	Pijlman,	2016).		Vesicular	 stomatitis	 virus	 (VSV)	 is	 a	 negative-strand	 (-RNA)	 virus	 spread	 by	insect	vectors	and	it	belongs	to	the	family	Rhabdoviridae	(Mead	et	al,	2000;	Lyles	
et	 al,	 2013).	 	 It	 usually	 infects	 livestock	 but	 can	 occasionally	 cause	 disease	 in	humans	(Lyles	et	al,	2013).	The	genome	of	VSV	is	about	11.2	kb	in	length,	and	it	lacks	 5’	 and	 3’	 UTRs	 (Lyles	 et	 al,	 2013;	 National	 Center	 for	 Biotechnology	Information,	 https://www.ncbi.nlm.nih.gov/nuccore/J02428,	 Coordinators,	2017).	 VSV	 virions	 are	 approximately	 200	 nm	 long	 with	 bullet-shaped	morphology	and	the	nucleocapsids	follow	helical	symmetry	(Ge	et	al,	2010).	Like	SFV,	 VSV	 enters	 host	 cells	 via	 endocytosis	 and	 the	 fusion	 of	 the	 host	 and	 VSV	membranes	 dependent	 on	 the	 low	 pH	 of	 the	 endosome	 (Regan	 &	 Whittaker,	
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2013).	However,	VSV	fusion	occurs	later	than	SFV	fusion	and	it	is	mediated	by	a	two-step	 fusion	 program	 (Le	 Blanc	 et	 al,	 2005).	 First	 the	 VSV	 nucleocapsid	 is	released	to	the	lumen	of	an	intra-endosomal	vesicle	and	it	enters	the	cytoplasm	later,	 following	 a	 back-fusion	 of	 the	 intra-endosomal	 vesicle	 (Le	 Blanc	 et	 al,	2005).	 The	 transcription	 and	 replication	 of	 VSV	 follows	 the	 general	 scheme	 of	non-segmented	 -RNA	 viruses	 (Lyles	 et	 al,	 2013).	 The	 genome	 is	 used	 as	 a	template	for	viral	mRNAs	and	a	+RNA-antigenome,	which	is	used	as	template	for	the	new	-RNA	genomes.		
2.3	The	role	of	host	factors	in	SFV	infection	Previously,	a	genome-wide	siRNA	screen	was	performed	to	identify	host	factors	that	affect	SFV	infection	(Balistreri	et	al,	2014).	The	screen	implicated	a	number	of	genes	(“hits”)	 (Table	1).	Following	 the	screen,	 the	roles	of	UPF1,	ATP6V1B2,	and	ATP6V1G1	in	SFV	infection	were	characterized	(Balistreri	et	al,	2014).		
Table	1.	Genes	implicated	in	SFV	infection	by	the	genome-wide	siRNA	screen.	
Gene	symbol	 Function	 Gene	ID*	 Gene	symbol	 Function	 Gene	ID*	PHB2	 Intracellular	signaling	 11331	 DDX31	 DEAD-box	helicase	 64794	EDF1	 Transcriptional	coactivation	 8721	 DDX41	 DEAD-box	helicase	 51428		SLC6A13	 GABA	&	taurine	transport	 6540		 DDX43	 DEAD-box	helicase	 55510		EIF2B3	 Translation	initiation	 8891		 DDX47	 DEAD-box	helicase	 51202		ETF1	 Translation	termination	 2107	 DDX54	 DEAD-box	helicase	 79039		EIF4G1	 Translation	initiation	 1981	 DHX37	 DEAH-box	helicase	 57647		DDX18	 DEAD-box	helicase	 8886		 DHX57	 DEAH-box	helicase	 90957		PVR	 Poliovirus	receptor	 5817		 KREMEN2	 Transmembrane	receptor	 79412		CSPG5	 Chondroitin	sulfate	proteoglycan	5	 10675		 HDAC6		 Deacetylation	of	various	proteins	 10013	GNPDA1	 Glucosamine-6-phosphate	deaminase	 10007		 DNM2	 Endocytosis	 1785		RPL18	 Ribosomal	protein	 6141		 AP2M1	 Vacuolar	ATPase	activation	 1173		UPF1	 mRNA	quality	control,	antiviral	activity	 5976		 CLTC	 Endocytosis	 1213		ATP6V1B2	 Vesicle	acidification	 526		 KPNB1	 Nuclear	localization	 3837		ATP6V1G1	 Vesicle	acidification	 9550	 TNPO1	 Intracellular	localization	 3842		*	O’Leary	et	al,	2016	
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The	 first	aim	of	 this	 thesis	was	to	confirm	the	roles	of	 the	hits	 in	SFV	 infection	and	 investigate	 if	 their	 effect	was	 specific	 to	 SFV.	 This	was	 done	 using	 siRNA-mediated	 knockdown	 and	 high-throughput	 imaging	 to	 determine	 if	 the	 hits	affected	SFV	and	VSV	infections.	The	second	aim	was	to	assign	a	role	in	the	early	(entry	 and	penetration),	 or	 later	 (post-penetration)	 stages	 of	 SFV	 infection	 for	the	confirmed	host	factors.	This	was	performed	using	a	similar	strategy	as	above	combined	with	an	assay	to	bypass	the	endocytosis	step	of	SFV	infection	(White	et	
al,	1980)	(Figure	2).		






3.1	Cell	lines	and	viruses	HeLa	 cells	 (ATCC)	 were	 cultured	 using	 Dulbecco’s	 Modified	 Eagle’s	 Medium	(DMEM)	 (Sigma-Aldrich,	 D7777)	 supplemented	with	 10	%	 fetal	 bovine	 serum	(FBS)	 (Sigma-Aldrich,	 F9665),	 GlutaMAX	 (Gibco,	 35050-061),	 Non-essential	Amino	 Acids	 Solution	 (Sigma-Aldrich,	 M7145),	 and	 Antibiotics	 &	 Antimycotics	Solution	 (Sigma-Aldrich,	 A5955)	 (HeLa	 growth	medium).	 BHK-21	 cells	 (ATCC)	were	 culture	 using	 Minimum	 Essential	 Medium	 (MEM)	 (Gibco,	 61100-087)	supplemented	with	 10	%	 FBS	 and	 GlutaMAX.	 The	 cells	were	 grown	 at	 +37	 °C	with	a	5%	CO2	atmosphere.		SFV	expressing	ZsGreen	protein	fused	with	the	virus	nsP	3	(SFV-ZsGreen)	(Spuul	
et	 al,	 2010)	 and	 rVSV-GFP,	 a	 VSV	 strain	 expressing	 green	 fluorescent	 protein	(GFP)	(Pelkmans	et	al,	2005)	have	been	previously	described.	The	viruses	were	originally	 produced	 at	 ETH	 Zurich	 (Switzerland)	 and	 were	 provided	 by	 Dr.	Balistreri	with	permission	from	professor	Ari	Helenius.		
3.2	Virus	production	and	titration		Virus	inocula	were	prepared	in	MEM	supplemented	with	20	mM	HEPES	(pH	7.2),	GlutaMAX,	 and	0.2	%	bovine	 serum	albumin	 (BSA)	and	confluent	BHK-21	cells	were	 washed	 twice	 with	 phosphate-buffered	 saline	 (PBS)	 and	 infected	 with	either	SFV-ZsGreen	or	rVSV-GFP	using	an	MOI	of	0.01	by	replacing	the	old	media	with	the	virus	inocula.	The	infected	cells	were	incubated	at	+37	°C	with	a	5%	CO2	atmosphere.	The	media	were	collected	after	22h	and	centrifuged	at	3900	rpm	for	20	 min	 (SFV-ZsGreen)	 or	 10	 min	 (rVSV-GFP)	 at	 +4	 °C	 (Eppendorf	 Centrifuge	5810R)	to	eliminate	cell	debris.	The	supernatants	were	collected,	aliquoted	and	stored	at	-80	°C.		HeLa	cells	were	seeded	onto	black	clear-bottom	96-well	plates	(Corning,	07-200-568)	at	a	density	of	10	000	cells	/	well	and	grown	for	16–20	h	at	+37	°C	with	a	5%	 CO2	 atmosphere.	 The	 cells	 were	 washed	 with	 DMEM	 supplemented	 with	GlutaMAX	and	Antibiotics	&	Antimycotics	Solution	(SFV-ZsGreen)	or	RPMI-1640	
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medium	(ICN,	1060122)	containing	20	mM	HEPES	pH	7.0	and	GlutaMAX	(rVSV-GFP)	 (100	μl	 /	well).	 The	 cells	where	 then	 infected	with	1:2	 (SFV-ZsGreen)	 or	1:10	 (rVSV-GFP)	 serial	 dilutions	 in	 duplicate	 using	 100	 μl	 of	 virus	 inocula	 in	corresponding	media	The	infected	cells	were	grown	for	6	h	(SFV-ZsGreen)	or	7	h	(rVSV-GFP)	at	+37	°C	with	a	5%	CO2	atmosphere.		After	 the	 incubation,	 the	media	were	 aspirated	 and	 the	 cells	were	 fixed	 for	20	min	at	room	temperature	(RT)	using	4	%	para-formaldehyde	(PFA)	in	PBS	(100	μl/	well).	The	fixed	cells	were	washed	3	times	with	PBS	(100	μl/	well).	The	cells	were	permeabilized	and	the	nuclei	stained	by	incubating	the	cells	for	10	min	at	RT	in	100	μl	of	PBS	containing	0.2	%	Triton	X-100	and	Hoechst	DNA	stain	(1	μg/	ml)	per	well.	The	cells	were	then	washed	3	times	with	PBS	(100	μl/	well)	and	the	plates	 covered	 with	 Black	 TopSeal-A	 plate	 seals	 (PerkinElmer,	 6050173)	 and	stored	at	+4	°C.	The	plates	were	 imaged	with	a	high-content	Cellinsight	 Imager	microscope	 (Thermo	 Fisher)	 at	 the	 Light	 Microscopy	 Unit,	 Institute	 of	Biotechnology.	16	 images	were	 taken	per	well,	 using	both	 the	386	nm	and	 the	485	nm	filters	to	visualize	the	fluorescence	signal	of	the	Hoechst	and	the	ZsGreen	or	GFP.	The	images	were	analyzed	using	the	open	source	Cellprofiler	2	software	(Carpenter	et	al,	2006,	www.cellprofiler.com)	(see	below).		
3.3	Virus	infections	of	siRNA-transfected	cells	HeLa	 cells	 were	 reverse	 transfected	 using	 pooled	 siRNAs	 (Dharmacon	SMARTpool	siRNAs)	on	a	black	clear-bottom	96-well	plate	using	a	separate	well	for	 each	 siRNA	 pool.	 The	 siRNA	 pools	 contained	 a	 mixture	 of	 4	 different	oligonucleotides	 against	 non-overlapping	 regions	 of	 each	 target	 gene	 in	equimolar	concentrations.	The	siRNA	pools	targeted	the	genes	of	interest	as	well	as	control	genes	(KIF11,	Ppbi	and	PPBI)	(table	S1).	The	siRNA	pool	against	KIF11	was	used	as	a	transfection	control.	Since	the	product	of	this	gene	is	essential	for	cell	 survival,	 monitoring	 cell	 death	 was	 used	 as	 a	 means	 to	 make	 sure	 the	transfection	was	efficient	(>98%	cell	death	indicated	successful	transfection).	A	mix	of	4	different	non-specific	 (or	 “scrambled”)	siRNAs	was	used	as	a	negative	control	in	four	separate	wells.	The	siRNAs	against	Ppbi	and	PPBI	were	supplied	by	the	manufacturer	as	easily	quantifiable	transfection	controls.		
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	For	each	well,	10	μl	of	a	siRNA	stock	(100	nM)	was	mixed	with	10	μl	of	DMEM	containing	0.1	μl	 of	Lipofectamine	2000	 (Invitrogen,	11668-019)	and	 the	plate	was	 incubated	 at	 RT	 for	 30–60	 min.	 Then	 for	 each	 well,	 2000	 HeLa	 cells	suspended	 in	 80	 μl	 of	DMEM	were	mixed	with	 the	 siRNA–Lipofectamine	 2000	mix	yielding	a	 final	siRNA	concentration	of	10	nM	per	well.	The	plate	was	then	incubated	at	+37	°C	with	a	5%	CO2	atmosphere	for	6	h,	after	which,	the	medium	was	replaced	with	HeLa	growth	medium	(200	μl/	well)	and	the	cells	were	grown	at	+37	°C	with	a	5%	CO2	atmosphere.			After	72	h	 the	old	media	were	removed	and	 the	cells	were	washed	with	either	DMEM	 supplemented	 with	 GlutaMAX	 and	 Antibiotics	 &	 Antimycotics	 Solution	(SFV-ZsGreen)	or	RPMI-1640	medium	(ICN,	1060122)	containing	20	mM	HEPES	pH	7.0	and	GlutaMAX	 (rVSV-GFP)	 (100	μl	 /	well).	The	cells	were	 then	 infected	with	100	μl	/	well	of	virus	inocula	containing	6*104	pfu	of	either	SFV-ZsGreen	or	rVSV-GFP	in	corresponding	media.	The	cells	were	incubated	at	+37	°C	with	a	5%	CO2	atmosphere	for	5	h	(SFV-ZsGreen)	or	6.5	h	(rVSV-GFP)	and	the	plates	were	fixed,	 stained,	 imaged,	 and	 analyzed	 as	 above.	 Three	 biological	 repetitions	 per	virus	were	performed.		
3.4	Endocytic	bypass	assay		HeLa	cells	were	reverse	 transfected	as	above.	72	h	after	 transfection,	 the	plate	was	placed	on	ice	and	cells	washed	with	ice-cold	RPMI-1640	medium	containing	20	mM	HEPES,	pH	7.0	(100	μl	/	well)	and	infected	on	ice	with	6*104	pfu	of	SFV-ZsGreen	 diluted	 in	 the	 same	medium	 (ice-cold)	 (100	 μl	 /	well).	 The	 plate	was	incubated	on	ice	for	1	h	and	the	medium	was	removed	from	the	wells.	To	allow	virus	 fusion	 with	 the	 PM,	 the	 cells	 were	 treated	 with	 RPMI-1640	 medium	containing	 10	 mM	 MES	 buffer,	 pH	 5.5	 for	 90	 s	 at	 +37	 °C.	 The	 medium	 was	aspirated	 and	 replaced	 with	 HeLa	 growth	 medium	 supplemented	 with	 20mM	NH4Cl	and	20mM	HEPES,	pH	7.2	(200	μl	/	well).	The	plate	was	incubated	at	+37	°C	with	5%	CO2	atmosphere	for	4	h	and	the	plate	was	fixed,	stained,	imaged,	and	analyzed	as	above.	Controls	included	wells	that	were	not	infected,	wells	treated	with	pH	7.0	medium	instead	of	the	pH	5.5	medium,	and	wells	treated	with	pH	7.0	
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medium	 and	 HeLa	 growth	 medium	 instead	 of	 the	 pH	 5.5	 medium	 and	 HeLa	growth	 medium	 with	 NH4Cl,	 respectively.	 Three	 biological	 repetitions	 were	performed.		
3.5	Automated	high-throughput	image	analysis	The	 Cellprofiler	 2	 software	 (Carpenter	 et	 al,	 2006,	 www.cellprofiler.com)	 was	used	to	determine	the	percentage	of	 infected	cells	 in	each	well.	 	 In	each	 image,	the	number	of	cells	was	determined	by	detecting	the	386	nm	fluorescence	signal	of	the	stained	nuclei,	designated	“primary	objects”	(Figure	3	A	&	B).	SFV-ZsGreen	produces	ZsGreen-labeled	nsP3,	thus	ZsGreen-expressing	cells	are	infected	with	SFV.	 For	 the	 SFV	 experiments	 the	 perimeter	 of	 each	 detected	 nucleus	 was	digitally	 expanded	 to	 include	 a	 portion	 of	 the	 cytoplasm	 around	 the	 nucleus,	designated	“secondary	objects”	(Figure	3	C,	D,	E	&	F).	This	was	done	to	detect	the	ZsGreen	signal	from	the	cytoplasm,	where	the	SFV	protein	synthesis	occurs.	The	mean	 fluorescence	 signal	 on	 the	 485	nm	 channel	 (ZsGreen)	was	measured	 for	each	 secondary	 object.	 For	 the	 rVSV-GFP-infected	 cells	 the	mean	 fluorescence	signal	on	 the	485	nm	channel	 (GFP)	was	measured	within	each	primary	object	(nucleus),	 as	 the	 GFP	 protein	 encoded	 by	 the	 virus	 was	 synthesized	 in	 the	cytoplasm	and	 freely	diffused	 into	 the	nucleus	of	 the	host	 indicating	successful	viral	translation.			Using	a	threshold	value	of	mean	485	nm	fluorescence,	the	cells	were	classified	in	two	 categories:	 infected	 (above	 threshold)	 and	non-infected	 (below	 threshold)	(Figure	4	G).	Non-infected	cells	were	always	included	to	calibrate	the	threshold	settings	 for	 each	 imaged	plate.	Once	 all	 images	 in	 each	well	 of	 a	 96	well	 plate	were	analyzed,	the	final	results	were	expressed	as	total	infected	cells	per	well.	To	calculate	virus	titers,	 the	estimated	amount	of	cells	per	well	(16,000)	(Rafferty,	1985)	 was	 multiplied	 with	 the	 percentage	 of	 infected	 cells	 to	 determine	 the	amount	of	infectious	virions	per	well.	In	the	siRNA	experiments,	cells	transfected	with	 non-targeting	 (or	 “scrambled”)	 siRNAs	 were	 used	 as	 controls.	 The	mean	number	of	infected	cells	in	the	scrambled	controls	was	set	as	1	and	the	infection	percentages	 in	 the	 remaining	 transfected	 wells	 were	 normalized	 accordingly.	The	 mean	 infection	 percentage	 per	 gene	 was	 calculated	 from	 three	 biological	
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repetitions.	 A	 difference	 of	 2	 or	 more	 standard	 deviations	 from	 controls	 was	considered	to	be	significant.			
	
Figure	3.	Automated	detection	of	infected	cells	using	Cellprofiler	2.	A	&	B:	Fluorescence	signal	detected	using	395	nm	(blue)	and	485	nm	(green)	filters	from	SFV-infected	cells	pre-treated	with	scrambled	control	siRNA.	 C:	 Automatically	 detected	 nuclei	 (pseudocoloured	 'primary	 objects').	 E–F:	 Pseudocoloured	secondary	objects	obtained	by	digitally	expanding	the	primary	objects	(D)	and	subtracting	the	area	of	the	primary	objects.	G:	The	secondary	objects	were	used	to	automatically	classify	infected	(red)	or	non-infected	(blue)	cells,	using	the	mean	fluorescence	intensity	from	the	485	nm	channel	(G).	
	
4.	Results	
	The	 aim	 of	 this	 thesis	was	 to	 study	 the	 effects	 of	 knocking	 down	 host	 factors	previously	 implicated	 in	 SFV	 infection,	 and	 compare	 those	 effects	 to	 VSV	infection.	 The	 genes	 affecting	 SFV	 infection	 were	 further	 characterized	 by	studying	 if	 they	affect	entry	and	penetration,	or	post-penetration	stages	of	SFV	infection.	
	
4.1	Knocking	down	previously	implicated	host	factors	affects	SFV	and	VSV	
infections	To	 determine	 which	 of	 the	 previously	 implicated	 genes	 affect	 SFV	 and	 VSV	infections,	 I	 used	 siRNA-mediated	 knockdown,	 high-throughput	 imaging	 and	automated	 image	 analysis.	 I	 found	 that	 both	 SFV	 and	 VSV	 infection	 could	 be	reduced	significantly	by	knocking	down	ATP6V1B2	and	ATP6VG1,	two	subunits	of	a	vacuolar	ATPase	know	to	affect	SFV	infection	(Balistreri	et	al,	2014)	as	well	
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as	 ribosomal	protein	L18	 (RPL18),	 a	part	 of	 the	60	S	 ribosomal	 subunit	 (de	 la	Cruz	et	al,	2015)	(Figures	4	&	5).	Both	SFV	and	VSV	infections	were	affected	by	the	 knockdown	 of	 transportin-1	 (TNP01),	 an	 intracellular	 transport	 molecule	(Twyffels	 et	 al,	 2014),	 prohibitin	 2	 (PHB2),	 an	 intracellular	 signaling	 protein	(Bavelloni	et	al,	2015),	and	DEAH-box	helicase	(DHX)	37,	a	poorly	characterized	RNA-helicase	 (Gene	 ID:	 57647)	 (Figures	 4	 &5).	 However,	 the	 knockdown	 of	these	 genes	 had	 the	 opposite	 effects	 on	 SFV	 and	 VSV	 infections,	 as	 TNP01	depletion	decreased	SFV	infection	and	increased	VSV	infection	significantly,	and	in	 the	 case	 of	 PBH2	 and	 DHX37	 depletions	 SFV	 infection	 increased	 and	 VSV	infection	decreased	significantly	(Figures	4	&	5).		
	
Figure	4.	Relative	infection	percentages	in	cells	depleted	of	host	factors	that	affect	both	SFV	and	VSV	








Figure	 5.	 Representative	 images	 of	 cells	 depleted	 of	 host	 factors	 that	 affect	 both	 SFV	 and	 VSV	
infections.	A:	HeLa	cells	infected	with	SFV-ZsGreen.	Nuclei	are	shown	in	blue	and	nsP3-ZsGreen,	indicating	SFV	 infection,	 is	 shown	 in	 green.	 The	 siRNAs	 used	 are	 indicated	 by	 the	 text	 in	 the	 images.	B:	HeLa	 cells	infected	with	VSV-GFP.	Nuclei	are	shown	in	blue	and	GFP,	indicating	VSV	infection,	is	shown	in	green.	The	siRNAs	used	are	indicated	by	the	text	in	the	images.		By	depleting	cells	of	solute	carrier	family	6	member	13	(SLC6A13),	a	GABA	and	taurine	transporter	(Kristensen	et	al,	2011;	Zhou	et	al,	2012),		GNPDA1,	a	poorly	characterized	 glucosamine-6-phosphate	 deaminase	 (Wolosker	 et	 al,	 1998),	DEAD-box	helicase	(DDX)	54,	an	RNA-helicase	that	has	a	transcription-regulating	role	in	cells	(Rajendran	et	al,	2003;	Kanno	et	al,	2012),		and	dynamin-2	(DMN2),	a	 protein	 involved	 in	 endocytosis	 (Kasai	 et	 al,	 1999),	 SFV	 infection	 could	 be	significantly	 reduced	 (Figures	 6	 &	 7).	 On	 the	 other	 hand,	 the	 knockdown	 of	eukaryotic	 translation	 initiation	 factor	 2B	 subunit	 γ	 (EIF2B3)	 and	 eukaryotic	translation	 initiation	 factor	 γ	 1	 (EIF4G1)	 (Walsh	 &	 Mohr,	 2011),	 eukaryotic	translation	 termination	 factor	 1	 (ETF1)	 (Taylor	 et	 al,	 2012),	 UPF1,	 an	 RNA-helicase	that	prevents	SFV	infection	(Balistreri	et	al,	2014),	DDX47	and	DHX57,	
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predicted	 RNA	 helicases	 (Gene	 IDs:	 51202	 and	 90957,	 respectively),	 histone	deacetylase	 6	 (HDAC6),	 a	 multifunctional	 cellular	 deacetylase	 (Hubbert	 et	 al,	2002),	and	endothelial	differentiation-related	 factor	1	(EDF1),	a	 transcriptional	co-activator	(Kabe	et	al,	1999)	 increased	SFV	infectivity	significantly	(Figures	6	&	7).	The	depletion	of	these	SFV-affecting	genes	had	no	significant	effect	on	VSV	infection	(Figures	6	&	7).	
	
Figure	 6.	 Relative	 infection	 percentages	 in	 cells	 depleted	 of	 host	 factors	 that	 affect	 only	 SFV	
infection.	The	relative	infection	percentages	of	siRNA-treated	HeLa	cells	infected	with	SFV-ZsGreen	(black)	or	VSV-GFP	(white)	are	indicated	on	the	y-axis.	The	siRNAs	used	are	indicated	on	the	x-axis.	The	infection	percentages	were	normalized	by	setting	the	mean	of	the	scrambled	controls	as	1.	The	error	bars	represent	standard	deviations	 of	 the	 tree	 repetitions	 and	 an	 asterisk	 signifies	 a	 result	 that	 is	 significantly	 different	from	the	control.		
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Figure	 7.	 Representative	 images	 of	 cells	 depleted	 of	 host	 factors	 that	 affect	 only	 SFV	 infection.	 A:	HeLa	cells	infected	with	SFV-ZsGreen.	Nuclei	are	shown	in	blue	and	nsP3-ZsGreen,	indicating	SFV	infection,	is	shown	in	green.	The	siRNAs	used	are	indicated	by	the	text	in	the	images.	B:	HeLa	cells	infected	with	VSV-GFP.	Nuclei	are	shown	 in	blue	and	GFP,	 indicating	VSV	 infection,	 is	 shown	 in	green.	The	siRNAs	used	are	indicated	by	the	text	in	the	images.	
	VSV	 infectivity	 was	 significantly	 increased	 by	 the	 depletion	 of	 the	 poliovirus	receptor	 (PVR)	 (Mendelsohn	 et	 al,	 1989),	 a	 Wnt/β-catenin-signaling	 receptor,	kringle	containing	transmembrane	protein	2	(KREMEN2)	(Mao	et	al,	2002),	and	adaptor	related	protein	complex	2μ	1	(AP2M1),	an	adaptor	of		endocytic	vesicles	and	 vATPases,	 (Heinaman,	 1995)	 (Figures	 8	 &	 9).	 Knocking	 down	 DDX18,	 a	poorly	 understood	 RNA-helicase	 (Dubaele	 &	 Chène,	 2007)	 and	 karyopherin	
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subunit	β	1	(KPNB1),	a	subunit	of	a	nuclear	import	protein	(Görlich	et	al,	1995)	decreased	VSV	infectivity	significantly	(Figures	8	&	9).	Curiously,	siRNAs	against	both	mouse	and	human	cyclophilin	B	(Ppib	and	PPBI,	respectively)	supplied	as	transfection	controls	by	the	manufacturer	increased	VSV	infectivity	significantly	(Figures	 8	 &	 9).	 Cyclophilin	 B	 is	 a	 multifunctional	 signaling	 and	 anti-inflammatory	protein	(Hoffmann	&	Schiene-Fischer,	2014).	None	of	these	genes	had	a	significant	effect	on	SFV	infectivity	(Figures	8	&	9).			
	
Figure	 8.	 Relative	 infection	 percentages	 in	 cells	 depleted	 of	 host	 factors	 that	 affect	 only	 VSV	
infection.	The	relative	infection	percentages	of	siRNA-treated	HeLa	cells	infected	with	SFV-ZsGreen	(black)	or	VSV-GFP	(white)	are	indicated	on	the	y-axis.	The	siRNAs	used	are	indicated	on	the	x-axis.	The	infection	percentages	were	normalized	by	setting	the	mean	of	the	scrambled	controls	as	1.	The	error	bars	represent	standard	deviations	 of	 the	 tree	 repetitions	 and	 an	 asterisk	 signifies	 a	 result	 that	 is	 significantly	 different	from	the	control.			
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Figure	 9.	 Representative	 images	 of	 cells	 depleted	 of	 host	 factors	 that	 affect	 only	 VSV	 infection.	 A:	HeLa	cells	infected	with	SFV-ZsGreen.	Nuclei	are	shown	in	blue	and	nsP3-ZsGreen,	indicating	SFV	infection,	is	shown	in	green.	The	siRNAs	used	are	indicated	by	the	text	in	the	images.	B:	HeLa	cells	infected	with	VSV-GFP.	Nuclei	are	shown	 in	blue	and	GFP,	 indicating	VSV	 infection,	 is	 shown	 in	green.	The	siRNAs	used	are	indicated	by	the	text	in	the	images.	
	The	depletion	of	some	of	the	genes	implicated	by	the	genome-wide	siRNA	screen	did	not	have	a	significant	effect	on	SFV	or	VSV	infection	(Figures	10	&	11).	These	included	 chondroitin	 sulfate	 proteoglycan	 5	 (CSPG5),	 a	 cell	 surface	 protein	expressed	 in	 the	 brain	 (Watanabe	 et	 al,	 1995),	 DDX31,	 an	 	 RNA-helicase	implicated	in	renal	cancer	(Fukawa	et	al,	2012),	DDX41,	an	RNA	helicase	with	a	role	 in	 cellular	 immunity	 (Jiang	 et	 al,	 2017),	 DDX43,	 a	 RNA	 and	 DNA	 helicase	(Tanu	et	al,	2017),	and	clathrin	heavy	chain	(CLTC),	a	well-studied	endocytosis	molecule	(Doherty	&	McMahon,	2009).		
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Figure	10.	Relative	 infection	percentages	 in	 cells	depleted	of	host	 factors	 that	do	not	affect	SFV	of	
VSV	 infections.	The	relative	 infection	percentages	of	siRNA-treated	HeLa	cells	 infected	with	SFV-ZsGreen	(black)	or	VSV-GFP	 (white)	 are	 indicated	on	 the	y-axis.	The	 siRNAs	used	are	 indicated	on	 the	x-axis.	The	infection	percentages	were	normalized	by	setting	the	mean	of	the	scrambled	controls	as	1.	The	error	bars	represent	standard	deviations	of	 the	 tree	repetitions	and	an	asterisk	signifies	a	result	 that	 is	significantly	different	from	the	control.		
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Figure	 11.	 Representative	 images	 of	 cells	 depleted	 of	 host	 factors	 that	 do	 not	 affect	 SFV	 of	 VSV	
infections.	A:	HeLa	cells	infected	with	SFV-ZsGreen.	Nuclei	are	shown	in	blue	and	nsP3-ZsGreen,	indicating	SFV	 infection,	 is	 shown	 in	 green.	 The	 siRNAs	 used	 are	 indicated	 by	 the	 text	 in	 the	 images.	B:	HeLa	 cells	infected	with	VSV-GFP.	Nuclei	are	shown	in	blue	and	GFP,	indicating	VSV	infection,	is	shown	in	green.	The	siRNAs	used	are	indicated	by	the	text	in	the	images		
4.2	Low	pH-Induced	PM	fusion	can	be	used	to	bypass	the	normal	entry	and	
penetration	steps	of	SFV	infection	To	 determine	 if	 depleted	 host	 factors	 play	 a	 part	 in	 the	 early	 stages	 (entry	 or	penetration)	 of	 SFV	 infection,	 these	 steps	 were	 circumvented	 by	 artificially	inducing	viral	envelope	fusion	at	the	PM	(White	et	al,	1980).	This	was	achieved	by	 allowing	 the	 viruses	 to	 bind	 cells	 on	 ice	 and	 treating	 the	 cells	 quickly	with	acidic	medium	 (pH	5.5).	This	 causes	 a	 conformational	 change	 in	 the	 SFV	 spike	
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proteins,	 which	 leads	 to	 membrane	 fusion,	 delivery	 of	 nucleocapsid	 into	 the	cytoplasm,	and	uncoating	of	the	nucleocapsid.	Since	within	the	90	second	of	low-pH	 treatment,	 some	SFV	virions	 are	 internalized	by	 endocytosis,	 after	 the	 acid	treatment	 cells	 were	 incubated	 in	 NH4Cl-containing	 medium	 at	 pH	 7.2	 which	neutralized	 the	 acidic	 pH	 of	 endosomes	 preventing	 these	 viruses	 from	 fusing	(Figure	12).	Compared	to	the	normal	route	of	SFV	infection,	the	endocytic	bypass	was	slightly	less	efficient,	restoring	about	60	%	of	infected	cells.	If	the	cells	were	not	treated	with	acidic	medium,	but	incubated	in	NH4Cl-containing	medium,	the	infection	percentage	dropped	to	the	level	of	non-infected	wells	(Figure	13).		
	




Figure	13.	HeLa	cells	can	be	infected	by	using	endocytic	bypass.	A:	The	relative	infection	percentages	of	HeLa	 cells	 infected	with	 SFV-ZsGreen	 from	 two	 repetitions	 are	 indicated	 on	 the	 y-axis.	 The	 indicated	 pH	values	refer	to	infection	with	no	fusion	on	the	PM	but	incubation	with	NH4Cl-containing	medium	(pH	7.0)	and	 infection	 with	 PM	 fusion	 and	 incubation	 with	 NH4Cl-containing	 medium	 (pH	 5.5).	 The	 infection	percentages	were	normalized	by	setting	the	mean	of	 the	normal	 infections	as	1.	The	error	bars	represent	standard	 deviations	 of	 the	 two	 repetitions.	 B:	 Representative	 images	 of	 HeLa	 cells	 infected	 with	 SFV-ZsGreen.	Nuclei	are	shown	in	blue	and	nsP3-ZsGreen,	indicating	SFV	infection,	is	shown	in	green.	The	text	in	the	images	indicates	different	infection	conditions	(see	A).	
	
4.3	SLC6A13	is	needed	in	the	early	stages	of	SFV	infection	SLC6A13,	also	known	as	GAT-2,	is	a	GABA	and	taurine	transporter	that	contains	12	hydrophobic	membrane-spanning	domains,	11	loop	regions	and	cytoplasmic	N	and	C	termini	(Kristensen	et	al,	2011;	Zhou	et	al,	2012).	On	the	3–4	loop	there	are	three	N-glycosylated	residues	(Figure	14)	(Kristensen	et	al,	2011).		This	PM	protein	 belongs	 to	 the	 solute-carrier	 6	 (SLC6)	 gene	 family,	 which	 contains	membrane	 proteins	 that	 transport	 neurotransmitters	 by	 utilizing	 Na+	 and	 Cl-	ions	(Kristensen	et	al,	2011).	As	it	seems	to	be	required	for	SFV	infection,	I	tested	if	it	is	needed	for	entry	and	penetration	steps	of	infection.	By	infecting	HeLa	cells	using	 endocytotic	 bypass,	 I	 could	 revert	 SFV	 infectivity	 back	 to	 the	 level	observed	 in	 the	 scrambled	 controls	 (Figure	 15).	 For	 further	 controls	 I	 used	siRNAs	against	ATP6V1B2,	ATP6V1G1,	and	UPF1.	ATP6V1B2	and	ATP6V1G1	are	known	 to	 be	 critical	 for	 the	 penetration	 of	 SFV,	 and	 UPF1	 works	 against	 SFV	
	 28	





Figure	 15.	 The	 roles	 of	 SLCA13	 and	DDX54	 in	 SFV	 infection.	 A:	The	 relative	 infection	percentages	of	siRNA-treated	HeLa	cells	infected	with	SFV-ZsGreen	normally	(black)	or	using	endocytic	bypass	(grey)	are	indicated	 on	 the	 y-axis.	 The	 siRNAs	 used	 are	 indicated	 on	 the	 x-axis.	 The	 infection	 percentages	 were	normalized	 by	 setting	 the	 mean	 of	 the	 scrambled	 controls	 as	 1.	 The	 error	 bars	 represent	 standard	deviations	 of	 the	 tree	 repetitions	 and	 an	 asterisk	 signifies	 a	 result	 that	 is	 significantly	 different	 from	 the	control.	 B:	 HeLa	 cells	 infected	 with	 SFV-ZsGreen	 normally	 or	 using	 endocytic	 bypass	 (indicated	 on	 the	right).	Nuclei	are	shown	in	blue	and	nsP3-ZsGreen,	indicating	SFV	infection,	is	shown	in	green.	The	siRNAs	used	are	indicated	by	the	text	in	the	images.	
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4.4	 TNP01	 and	 HDAC6	 affect	 the	 entry	 and	 penetration	 steps	 of	 SFV	
infection.	TNP01	 is	 a	 cellular	 transport	molecule	 implicated	 in	nuclear	 transport,	mitotic	spindle	assembly,	nuclear	envelope	assembly,	ciliary	 import,	and	the	 formation	of	P	bodies	and	stress	granules	(Twyffels	et	al,	2014).	HDAC6	is	member	of	the	histone	 deacetylase	 (HDAC)	 family,	 but	 unlike	 other	 HDACs,	 it	 has	 also	 non-histonic	targets	and	has	a	ubiquitin-binding	zinc-finger	domain	(Li	et	al,	2013).	Both	TNP01	and	HDAC6	have	roles	in	cellular	stress	responses	(Kawaguchi	et	al,	2003;	Twyffels	et	al,	2014)	and	seem	to	have	role	in	SFV	infection,	even	though	the	effect	of	HDAC6	is	minuscule.	 In	the	endocytic	bypass	assay,	SFV	infectivity	was	 not	 significantly	 different	 from	 the	 controls	 in	 both	 TNP01	 and	 HDAC6-depleted	cells	(Figure	16).	This	indicates	that	their	roles	are	related	to	the	early	stages	of	SFV	infection.		
4.5	Components	of	the	translation	machinery	affect	penetration	and	post-














Figure	18.	The	roles	of	different	translational	machinery	components	in	SFV	infection.	A:	The	relative	infection	 percentages	 of	 siRNA-treated	 HeLa	 cells	 infected	 with	 SFV-ZsGreen	 normally	 (black)	 or	 using	endocytic	 bypass	 (grey)	 are	 indicated	 on	 the	 y-axis.	 The	 siRNAs	 used	 are	 indicated	 on	 the	 x-axis.	 The	infection	percentages	were	normalized	by	setting	the	mean	of	the	scrambled	controls	as	1.	The	error	bars	represent	standard	deviations	of	 the	 tree	repetitions	and	an	asterisk	signifies	a	result	 that	 is	significantly	different	 from	 the	 control.	B:	 HeLa	 cells	 infected	 with	 SFV-ZsGreen	 normally	 or	 using	 endocytic	 bypass	(indicated	on	the	right).	Nuclei	are	shown	in	blue	and	nsP3-ZsGreen,	 indicating	SFV	infection,	 is	shown	in	green.	The	siRNAs	used	are	indicated	by	the	text	in	the	images.	
	
4.6	SFV	infection	is	affected	by	other	host	factors	in	penetration	and	post-
penetration	steps	SFV	 infectivity	 could	 be	 increased	 by	 using	 siRNAs	 against	 PHB2,	 EDF1,	 ETF1,	DDX47,	 DHX37,	 and	 DHX57.	 DDX47	 and	 DHX57	 are	 probable	 RNA	 helicases	(Gene	 IDs:	 51202	 and	 90957,	 respectively),	 DDX54	 is	 a	 RNA	 helicase	 that	functions	in	transcription	regulation	(Rajendran	et	al,	2003;	Kanno	et	al,	2012),		PHB2	 and	 EDF1	 are	 implicated	 in	 transcriptional	 processes	 (Kabe	 et	al,	 1999;	Bavelloni	 et	al,	 2015),	 and	ETF1	 is	 known	 to	 interact	with	 nonsense-mediated	decay	 (Czaplinski	 et	 al,	 1998),	 which	 is	 a	 part	 of	 the	 host	 antiviral	 defense	
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(Balistreri	 et	 al,	 2014).	 Therefore	 my	 hypothesis	 was	 that	 all	 of	 these	 factors	would	have	post-penetrational	effects.	The	effects	of	PHB2	and	EDF1	depletion	were	 similar	 in	 the	 endocytic	 bypass	 and	 normal	 infection	 (Figure	 19)	 so	 I	concluded	that	their	effects	are	not	related	to	SFV	entry	or	penetration.	In	ETF1,	DDX47	and	DHX37-depleted	cells	the	infectivity	was	not	statistically	significantly	different	 from	 the	 controls,	 but	 for	 DDX47	 and	 DHX37	 it	 was	 still	 high	 and	comparable	 to	 the	 infectivity	 in	 the	normal	 infection	assay	 (2-fold	and	1.5-fold	higher	than	controls,	respectively)	(Figure	19).	Curiously,	in	the	DHX57-depleted	cells,	the	effect	of	the	endocytic	bypass	was	the	opposite	of	the	normal	infection,	as	the	infectivity	was	significantly	lower	than	in	controls	(opposed	to	higher	than	in	controls	in	the	normal	infection).		The	depletion	of	GNPDA1	and	DMN2	decreased	SFV	infectivity.	As	DMN2	has	a	crucial	role	in	endocytosis	(Kasai	et	al,	1999),	I	assumed	that	effect	of	knocking	it	down	would	be	limited	to	the	early	stages	of	SFV	infection.	GNPDA1,	on	the	other	hand,	 is	a	poorly-characterized	glucosamine-6-phosphate	deaminase	(Wolosker	
et	 al,	 1998)	 so	 it	 was	 difficult	 to	 hypothesize	 how	 it	 affects	 SFV	 infection.	 By	using	endocytic	bypass	assay,	the	effect	of	the	siRNA	treatments	against	GNPDA1	and	 DMN2	 were	 reversed,	 so	 it	 seems	 that	 they	 both	 have	 roles	 in	 the	 early	stages	of	SFV	infection	(Figure	19).		
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Figure	 19.	 The	 roles	 of	 PHB2,	 EDF1,	 ETF1,	 DDX47,	 DHX37,	 DHX57,	 GNPDA1,	 and	 DMN2	 in	 SFV	















infection*	PHB2	 +	 -	 DDX41	 0	 0		EDF1	 +	 0	 DDX43	 0	 0	SLC6A13	 -	 	 DDX47	 +	 0	EIF2B3	 +	 0	 DDX54	 -	 0	ETF1	 +	 0	 DHX37	 +	 -	EIF4G1	 +	 0	 DHX57	 +	 0	DDX18	 0	 -	 KREMEN2	 0	 +	PVR	 0		 +	 HDAC6		 +	 0	CSPG5	 0		 0	 DNM2	 -	 0	GNPDA1	 -		 0	 AP2M1	 0	 +	RPL18	 -	 -	 CLTC	 0	 0	UPF1	 +	 0	 KPNB1	 0	 -	ATP6V1B2	 -	 -	 TNPO1	 -	 +	ATP6V1G1	 -	 -	 Ppbi	 0	 +	DDX31	 0	 0	 PPBI	 0	 +	*	+	=	siRNA	treatment	increases	infection,	-	=	siRNA	treatment	decreases	infection,	0	=	siRNA	treatment	has	no	effect	on	infection		By	using	the	endocytic	bypass	assay,	I	pinpointed	the	roles	of	SLC6A13,	TNP01,	HDAC6,	 RPL18,	 ETF1,	 and	 GNDPA1	 to	 the	 early	 events	 in	 SFV	 infection.	 I	 also	employed	the	same	method	to	assign	post-penetration	roles	for	DDX54,	EIF2B3,	PHB2,	 and	 EDF1.	 My	 results	 also	 confirmed	 the	 previously	 reported	 roles	 of	ATP6V1B2	and	ATP6V1G1	 in	 the	 early	 stages	 of	 SFV	 infection	 (Balistreri	et	al,	2014).	 In	 the	 case	 of	 EIF4G1,	 DDX47,	 and	 DHX37	 the	 mean	 infectivity	 in	 the	endocytic	bypass	was	similar	to	normal	infection,	even	though	the	difference	was	not	 statistically	 significant.	 In	 all	 cases	 this	 was	 caused	 by	 a	 single	 outlying	
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repetition	(data	not	shown),	so	I	am	inclined	to	believe	that	these	factors	affect	the	 later	 stages	 of	 SFV	 infection.	 Similarly,	 in	 the	 endocytic	 bypass	 assay	 the	mean	 infectivity	 in	UPF1-depleted	cells	was	not	significantly	different	 form	the	control	 because	 of	 a	 single	 outlier	 (data	 not	 shown).	 Still,	 the	mean	 infectivity	was	 similar	 to	 the	normal	 infection,	 and	almost	 two	 times	 that	of	 the	 controls.	Furthermore,	 UPF1	 has	 been	 reported	 to	 prevent	 the	 translational	 and	transcriptional	 stages	of	 SFV	 infection	 (Balistreri	et	al,	 2014).	 Curiously,	 in	 the	normal	 infection,	 DHX57	 depletion	 increased	 SFV	 infection	 significantly	 but	 in	the	endocytic	bypass,	virus	infectivity	was	significantly	lower	than	in	controls.		
5.2.	SLC6A13	is	a	candidate	receptor	for	SFV		SLC6A13	 is	 structurally	 similar	 to	 the	 iron	 transporter	 NRAMP2	 (natural	resistance	associated	macrophage	protein	2)	(Nevo	&	Nelson,	2006;	Kristensen	
et	al,	2011).	They	both	belong	to	 the	same	family	of	solute-carrying	membrane	proteins	 that	 have	 12	 membrane-spanning	 domains	 and	 cytosolic	 N-	 and	 C-termini	 (Nevo	 &	 Nelson,	 2006;	 Kristensen	 et	 al,	 2011).	 NRAMP2	 is	 used	 as	 a	receptor	in	both	insect	and	mammalian	cells	by	Sindbis	virus,	an	alphavirus	that	is	 closely	 related	 to	 SFV	 (Rose	 et	 al,	 2012).	 Therefore	 SLC6A13	 might	 be	 the	receptor	 for	 SFV.	This	 is	 further	 supported	by	 the	 fact	 that	 SLC6A13	depletion	does	 not	 affect	 VSV	 infectivity,	 as	 receptors	 are	 often	 virus-specific	 (Grove	 &	Marsh,	2011).	Additionally,	SLC6A13	mRNA	is	transcribed	heavily	in	the	kidneys	(The	 Human	 Protein	 Atlas,	 http://www.proteinatlas.org/ENSG00000010379-SLC6A13/tissue,	 Fagerberg	 et	 al,	 2014).	 The	 currently	 used	 SFV	 strains	 have	been	 passaged	 multiple	 times	 in	 hamster	 kidney	 (BHK-21)	 cells	 (Atkins	 et	 al,	1999)	 and	 the	 reason	 that	BHK-21	 cells	 support	high	 titers	 of	 SFV	may	be	 the	presence	 of	 the	 hamster	 analogue	 of	 SLC6A13.	 	 Passaging	 has	 affected	 SFV	binding	by	selecting	for	single	amino	acid	mutations	in	the	envelope	proteins	of	the	 virus	 which	 allows	 SFV	 to	 bind	 to	 host	 heparan	 sulphate	 via	 simple	electrostatic	interactions	(Smit	et	al,	2002).	However	binding	to	host	receptors	is	more	 complicated	 than	 binding	 on	 the	 surface,	 as	 it	 involves	multiple	 specific	interactions	 between	 viral	 and	 host	 proteins	 (Marsh	&	Helenius,	 2006).	 These	events	 need	 to	 be	 complex	 enough	 signal	 the	 host	 to	 initiate	 the	 endocytic	program	(Marsh	&	Helenius,	2006).	 It	 is	 therefore	conceivable	 that	adapting	 to	
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completely	new	receptors	 is	 an	unlikely	event	even	 in	 cell	 culture,	 and	viruses	may	 retain	 specificity	 for	 suitable	 receptors	 on	 the	 surface	 of	 the	 cells	 from	which	they	are	produced.		To	confirm	the	role	of	SLC6A13	in	SFV	infection,	further	experiments	are	needed.	We	will	test	if	SLC6A13-depletion	blocks	SFV	entry	(as	opposed	to	penetration)	using	 single-virus	 tracking	 in	 living	 cells	 and	 (Hoornweg	 et	 al,	 2016).	We	will	also	 use	 fluorescent	 immunolabeling	 and	 confocal	microscopy	 to	 compare	 the	rate	of	SFV	endocytosis	in	SLC6A13-depleted	and	wild	type	cells	(Rizopoulos	et	
al,	 2015).	 Furthermore,	 will	 determine,	 if	 the	 transfection	 of	 a	 SLC6A13-producing	 plasmid	will	 rescue	 SFV	 infection	 in	 conditional	 SLC6A13-knockout	cells.	 To	 further	 characterize	 the	 potential	 interaction	 between	 SLC6A13	 and	SFV,	a	structural	approach	is	needed.	This	may,	for	example,	be	in	the	form	of	X-ray	 crystallography	 of	 the	 SFV	 spike	 proteins	 complexed	 with	 a	 SLC6A13	extracellular	 domain	 or	 domains	 (Peng	 et	 al,	 2011),	 or	 a	 cryo-electron	microscopy	 single-particle	 reconstruction	 of	 SFV	 bound	 to	 SLC6A13	 (He	 et	 al,	2002).		
5.3.	Host	factors	that	affect	SFV	infection		The	fact	that	TNP01	RPL18,	and	ETF1	are	needed	for	SFV	entry	and	penetration	stages	 is	surprising	as	TNP01	 is	 involved	 in	 intracellular	 trafficking	and	RPL18	and	ETF1	have	canonical	roles	 in	translation	(Taylor	et	al,	2012;	Twyffels	et	al,	2014;	 de	 la	 Cruz	 et	 al,	 2015).	 TNP01	 is	 used	 by	 adenoviruses	 (Hindley	 et	 al,	2007),	 human	 immunodeficiency	 virus	 1	 (HIV-1)	 (Arnold	 et	 al,	 2006),	 and	human	papillomavirus	(Darshan	et	al,	2004)	for	the	nuclear	transport	of	various	virus	 components.	 As	 the	 effect	 of	 TNP01	 depletions	 are	 reversed	 by	 the	endocytic	 bypass	 assay,	 this	 cellular	 protein	must	 be	 needed	 in	 the	 very	 early	stages	of	SFV	infection.	Therefore,	a	role	in	the	later	steps	of	the	virus	life	cycle,	such	as	 interference	with	stress	granule	 formation	or	TNP01-mediated	nuclear	import	 of	 viral	 replicase	 protein	 nsP2	 (Twyffels	 et	 al,	 2014;	 Fros	 &	 Pijlman,	2016),	are	unlikely	 to	be	 related	 to	 the	observed	phenotypes.	 	 It	might	also	be	that	the	effect	of	TNP01	depletion	is	indirect	and	it	affects	the	function	of	some	other	proteins	that	have	roles	in	SFV	infection.		
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In	 the	 case	 of	 VSV,	 the	 known	 role	 of	 TNP01	 in	 stress	 granule	 formation,	 a	process	that	is	considered	as	a	mechanism	of	intrinsic	antiviral	immunity	may	be	the	 reason	why	 TNP01	 depletion	 increases	 VSV	 infection	 (Beckham	&	 Parker,	2008;	Twyffels	et	al,	2014).	It	has	previously	been	reported	that	the	knockout	of	TIA-1,	 a	 stress	 granule-associated	 protein,	 increases	 the	 infectivity	 of	 VSV	 in	mouse	 embryonic	 fibroblasts	 (Li	 et	 al,	 2002),	 which	 further	 supports	 this	hypothesis.		Based	on	the	interaction	of	RPL18	and	other	viruses,	one	would	expect	RPL18	to	affect	 the	 late	 stages	 of	 SFV	 infection.	 This	 ribosomal	 protein	has	 a	 role	 in	 the	translation	 or	 replication	 of	 Dengue	 virus	 (Cervantes-Salazar	 et	 al,	 2015),	cauliflower	mosaic	virus	(Leh	et	al,	2000)	and	HCV	(Dhar	et	al,	2006).	However,	in	SFV	infection,	RPL18	functions	in	the	early	stages	of	the	viral	life	cycle,	which	indicates	 a	 mechanism	 different	 from	 the	 other	 known	 viruses.	 It	 has	 been	shown	that	ribosomes	are	needed	in	the	uncoating	of	SFV	nucleocapsids	(Singh	&	Helenius,	1992).	Thus,	RPL18	might	have	a	role	 in	this	process,	which	would	be	a	function	unlike	any	described	for	a	ribosomal	protein	so	far.	However,	this	would	also	mean	that	during	the	endocytic	bypass	assay,	when	the	nucleocapsids	are	delivered	directly	to	the	cytoplasm	through	the	PM,	SFV	virions	are	uncoated	in	a	different	way	than	during	the	normal	entry.	This	unexpected	result	may	also	be	 caused	 by	 an	 indirect	 interaction	 of	 RPL18	 and	 some	 other	 cellular	 factor,	which	is	perturbed	by	the	depletion	of	RPL18.	As	I	did	not	investigate	at	which	stage	of	VSV	infection	RPL18	affects,	my	working	hypothesis	 is	that	 it	probably	affects	the	replication	or	translation,	as	has	been	reported	for	other	viruses	(Leh	
et	al,	2000;	Dhar	et	al,	2006;	Cervantes-Salazar	et	al,	2015).		ETF1	is	another	protein	that	seemed	to	be	related	to	the	post-entry	stages	of	SFV	infection.	 ETF1	 is	 a	 eukaryotic	 translation	 termination	 factor,	 with	 a	 role	 in	nonsense-mediated	 decay	 (Czaplinski	 et	al,	 1998),	 a	 pathway	 that	 is	 known	 to	counteract	 SFV	 infection	 during	 translation	 and	 replication	 (Balistreri	 et	 al,	2014).	 Thus,	 I	 initially	 assumed	 that	 ETF1	 would	 have	 a	 role	 in	 the	 post-penetration	stages	of	SFV	infection.	My	results	rule	out	this	possibility,	because	the	 effect	 of	 ETF1	 depletion	 was	 reversed	 by	 the	 endocytic	 bypass	 assay.	
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Therefore,	 it	might	 be	 that	 the	 effect	 I	 have	 observed	 is	 indirect,	 or	 ETF1	 has	previously	uncharacterized	functions.	Additionally,	these	functions	do	not	seem	to	be	broadly	antiviral,	as	ETF1-depletion	had	no	effect	on	VSV	infection.		HDAC6	is	used	by	 influenza	A	virus	(IAV)	to	uncoat	 its	genome	(Banerjee	et	al,	2014).	 It	 is	 also	 reported	 to	 inhibit	 oncolytic	 herpes	 simplex	 virus	 infection	 in	glioma	cells,	apparently	by	interfering	with	endocytic	trafficking	(Nakashima	et	
al,	 2015).	 As	 our	 initial	 result	 showed	 small	 but	 reproducible	 increase	 in	 SFV	infection	followed	by	HDAC6	knockdown,	I	assumed	that	it	plays	a	minor	role	in	SFV	entry	and	penetration	processes	as	HDAC6	has	a	role	 in	 the	positioning	of	endosomes	 (Li	 et	 al,	 2013).	 This	 was	 confirmed	 by	 endocytic	 bypass.	Surprisingly	HDAC6	depletion	did	not	affect	VSV	 infection,	even	though	HDAC6	has	been	reported	to	protect	mice	from	VSV	(Choi	et	al,	2016).	This	may	indicate	that	 cell	 culture	differs	 significantly	 from	 in	vivo	conditions	or	 that	HDAC6	has	different	roles	in	mouse	and	human	cells.	It	is	also	possible	that	HDAC6	functions	in	 the	 very	 late	 stages	 of	 VSV	 infection,	 such	 as	 egress,	 as	 our	 assay	 only	quantifies	viral	replication	and	not	the	later	stages	of	infection.			DMN2	is	another	protein	with	a	function	in	endocytosis	(Kasai	et	al,	1999),	and	therefore	 it	 was	 expected	 that	 its	 depletion	 would	 reduce	 SFV	 infectivity	 by	affecting	 the	early	steps	of	 the	 infection.	The	role	of	DMN2	 in	virus	 infection	 is	well	 characterized,	 and	 it	 is	 needed	 for	 example	 by	 bovine	 ephemeral	 virus,	hepatitis	E	virus,	and	Pichindé	virus	(Vela	et	al,	2008;	Cheng	et	al,	2012;	Holla	et	
al,	2015).	Surprisingly	it	was	not	required	by	VSV,	even	though	it	is	reported	to	be	crucial	for	VSV	entry	(Cureton	et	al,	2009;	Johannsdottir	et	al,	2009).		In	cells,	EIF2B3	and	EIF4G1	function	 in	transcription	 initiation	(Walsh	&	Mohr,	2011).	EIF2B3	is	a	component	of	eIF2B,	which	recycles	eIF2,	a	key	factor	in	the	formation	 of	 the	 43	 S	 pre-initiation	 complex	 and	 EIF4G1	 has	 a	 function	 in	bringing	 the	 mRNA	 cap	 and	 poly-A	 tail	 together	 in	 the	 48	 S	 pre-initiation	complex	(Walsh	&	Mohr,	2011).	As	a	part	of	the	host’s	broad	antiviral	response	that	aims	to	shut	down	translation,	eIF2	can	be	 inactivated	by	phosphorylation	(Walsh	&	Mohr,	2011).	SFV	can	counteract	this	response,	and	is	known	to	be	able	
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to	translate	its	structural	genes	even	in	the	presence	of	phosphorylated	eIF2.	As	the	depletion	of	EIF2B3	increases	SFV	infection	in	the	post-penetration	stages,	it	seems	 that	 SFV	 can	 translate	 even	 its	 early	 genes	 without	 a	 canonical	 set	 of	translation	initiation	factors.	Knocking	down	EIF4G1	similarly	affects	later	stages	of	 SFV	 infection	 and	 increases	 SFV	 infectivity.	 This	 shows	 that	 though	 cap-dependent,	the	translation	of	SFV	early	genes	does	not	occur	in	exactly	the	same	way	 as	 the	 translation	 of	 host	mRNAs.	 Since	 SFV	 RNA	 is	 not	 as	 susceptible	 to	changes	in	the	composition	of	the	translation	initiation	complex	as	host	mRNAs	are,	it	gains	an	advantage	in	the	translational	competition.		As	the	knockdown	of	EIF4G1	or	EIF2B3	does	not	affect	VSV	infection,	their	function	is	most	likely	not	broadly	antiviral.	This	indicates	that	SFV	has	evolved	some	mechanism	to	benefit	from	 the	 depletion	 of	 these	 host	 factors	while	 VSV	 has	 not.	Most	 likely	 this	 is	difference	 is	 mediated	 by	 the	 differences	 in	 SFV	 (sub)genomic	 RNA	 and	 VSV	mRNAs.		PHB2	 knockdown	 increased	 SFV	 infectivity	 during	 the	 post-penetration	 steps	and	 it	 also	 increased	VSV	 infectivity.	PHB2	has	been	reported	 to	be	a	pro-viral	agent	 for	 HIV-1	 (Emerson	 et	 al,	 2010)	 and	 to	 associate	 with	 severe	 acute	respiratory	 syndrome	 coronavirus	 nsPs	 (Cornillez-Ty	 et	 al,	 2009).	 Curiously,	PHB2-depletion	 has	 been	 previously	 shown	 to	 reduce	 VSV	 infection	 in	mouse	cells	 (Kreit	 et	 al,	 2015).	 The	 different	 result	 reported	 here	 might	 be	 due	 to	different	 roles	 of	 PHB2	 in	 murine	 and	 human	 cells,	 or	 differences	 in	 VSV	infection	 between	 these	 two	 organisms.	 Additionally,	 Kreit	 et	 al	 (2015)	 used	small	 hairpin	 RNA	 technology,	 opposed	 to	 siRNAs	 used	 in	 this	 study.	 Even	though	 these	methods	 are	 highly	 similar,	 this	may	 have	 a	 role	 in	 the	 differing	results.	 As	 PHB2	 interacts	 with	 a	 myriad	 of	 host	 processes	 and	 proteins	(Bavelloni	et	al,	2015),	it	is	possible	that	the	effects	of	its	depletion	are	indirect	and	 the	 actual	 effects	 are	 mediated	 by	 other	 host	 factors.	 PHB2	 is	 also	 a	transcriptional	 regulator	 (Bavelloni	 et	 al,	 2015)	 so	 its	 knockdown	 may	 just	reduce	host	 translation,	 thus	giving	 the	viral	RNAs	an	edge	 in	 the	 translational	competition.	 This	 may	 also	 be	 the	 mechanism	 by	 which	 EDF1-depletion	promotes	both	SFV	and	VSV	infectivity,	as	it	is	a	transcriptional	activator	(Kabe	
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et	 al,	 1999).	 This	 is	 further	 supported	 by	 the	 fact	 that	 the	 effect	 of	 EDF1	knockdown	affects	the	later	stages	of	SFV	infection.		GNDPA1,	 DDX54,	 DDX47,	 DHX37,	 and	 DHX57	 are	 all	 poorly	 characterized	cellular	 factors	 that	 have	 not	 been	 previously	 implicated	 in	 viral	 infections.	DDX47,	 DHX37,	 and	 DHX57	 are	 predicted	 RNA	 helicases	 (Gene	 IDs:	 51202,	57647,	 and	 90957,	 respectively).	 DDX54	 is	 an	 RNA-helicase	 that	 has	 been	reported	to	be	a	transcriptional	co-repressor	(Rajendran	et	al,	2003;	Kanno	et	al,	2012).	 The	 knockdown	 of	 DDX53,	 and	 DDX47	 increased	 SFV	 infection	 by	affecting	 the	 post-penetration	 stages,	 but	 had	 no	 effect	 on	 VSV	 infection.	 This	may	indicate	that	both	of	these	helicases	can	target	RNA	structures	found	in	SFV	but	 not	 in	 VSV.	 Or	 possibly	 SFV	 but	 not	 VSV	 requires	 these	 helicases	 for	translation	 or	 transcription.	 DHX37	 depletion	 affected	 both	 SFV	 and	 VSV	infections.	It	decreased	SFV	infection,	by	affecting	the	late	stages,	and	increased	VSV	infection.	This	may	be	due	to	a	similar	situation	as	above,	but	with	DHX37	depletion	 affecting	 host	 RNAs	 in	 a	 way,	 that	 allows	 VSV	 to	 succeed	 in	 the	translational	competition	against	the	host.	It	is	difficult	to	hypothesize	the	reason	why	 DHX57	 depletion	 was	 beneficial	 to	 SFV	 in	 the	 normal	 infection,	 but	detrimental	in	the	endocytic	bypass.	This	may	be	due	to	a	complex	role	of	DHX57	or	merely	 experimental	 anomalies.	 GNDPA1	 is	 a	 highly	 conserved	protein	 that	plays	 a	 crucial	 role	 in	 metabolism	 (Wolosker	 et	 al,	 1998).	 It	 is,	 therefore,	surprising	 that	 it	 would	 have	 a	 role	 in	 the	 early	 stages	 of	 SFV	 infection.	 This	effect	 would	 imply	 that	 GNDPA1	 has	 previously	 uncharacterized	 functions,	 or	that	its	depletion	affects	other	host	factors	that,	in	turn,	affect	SFV	infection.	
	
5.4.	Other	host	factors	Apparently,	 VSV	 infection	 is	 counteracted	 by	 PVR,	 KREMEN2,	 AP2M1	 and	cyclophilin	 B.	 On	 the	 other	 hand	 VSV	 seems	 to	 need	 ATP6V1B2,	 ATP6V1G1,	DDX18,	 and	 KPNB1	 for	 successful	 infection.	 The	 requirement	 of	 the	 vATPase	subunits	 ATP6V1B2	 and	 ATP6V1G1	 by	 VSV	 is	 not	 surprising,	 as	 it	 penetrates	host	membranes	via	pH-dependent	fusion	(Regan	&	Whittaker,	2013).	PVR	and	KREMEN2	are	cell	surface	molecules	(Mendelsohn	et	al,	1989;	Mao	et	al,	2002)	and	 AP2M1	 is	 a	 part	 of	 AP2,	 and	 therefore	 has	 a	 role	 in	 clathrin-mediated	
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endocytosis	 (Heinaman,	1995;	Boucrot	et	al,	 2010).	Therefore	 it	 is	 conceivable	that	these	molecules	would	affect	VSV	entry	or	penetration.		DDX18	is	a	poorly-studied	putative	RNA	helicase	for	which	helicase	activity	has	not	been	demonstrated	yet	(Dubaele	&	Chène,	2007).	If	DDX18	does	affect	RNA,	the	 effect	 of	 its	 depletion	 on	 VSV	 but	 not	 SFV	 infection	 may	 be	 due	 to	 VSV	containing	 some	 RNA	motif	 that	 SFV	 lacks,	 or	 vice	 versa.	 KPNB1	 is	 a	 protein	required	 for	 nuclear	 import	 (Görlich	 et	 al,	 1995)	 and	 its	 depletion	 greatly	reduces	VSV	infection.	It	has	been	previously	shown	that	the	M	protein	of	VSV	is	transported	 into	 the	 nucleus,	 which	 allows	 it	 to	 reduce	 nucleocytoplasmic	transport	(Petersen	et	al,	2000;	Glodowski	et	al,	2002).	Perhaps	the	transport	of	the	M	protein	is	mediated	by	KPNB1,	which	reduces	the	transport	of	host	mRNAs	into	 the	 nucleus,	 therefore	 giving	 VSV	 the	 upper	 hand	 in	 the	 translational	competition.		Cyclophilins	 affect	 the	 infections	 of	multiple	 viruses	 (Frausto	 et	 al,	 2013)	 and	cyclophilin	A	has	been	 reported	 to	be	 required	by	VSV	 for	 successful	 infection	(Bose	et	al,	2003).	The	siRNAs	against	PPBI	increased	infectivity	more	than	the	siRNAs	against	Ppbi.	Most	likely	this	effect	is	explained	by	sequence	dissimilarity	between	 human	 and	mouse	 cyclophilin	 B	 as	 the	 use	 of	 Ppbi-targeting	 siRNAs	would	result	in	only	partial	knockdown	of	PPBI	(Petersen	et	al,	2000;	Glodowski	
et	al,	2002).		CSPG6,	 a	 chondroitin	 sulfate	 proteoglycan	 (Watanabe	 et	 al,	 1995),	 DDX31,	 an	RNA-helicase	with	a	possible	role	 in	renal	carcinogenesis	(Fukawa	et	al,	2012),	DDX41	a	RNA	helicase	with	 functions	 in	 immune	processes	 (Jiang	et	al,	 2017),	DDX43,	 an	 RNA	 and	 DNA	 helicase	 (Tanu	 et	 al,	 2017),	 and	 CLTC,	 a	 well-characterized	endocytic	protein	(Doherty	&	McMahon,	2009)	did	not	have	roles	in	SFV	of	VSV	infections.	Chondroitin	sulfate	proteoglycans	have	been	implicated	in	the	binding	of	viruses	to	host	cells	(Banfield	et	al,	1995;	Hsiao	et	al,	1999),	but	SFV	and	VSV	apparently	do	not	utilize	 it,	at	 least	exclusively.	This	 is	consistent	with	the	report	that	SFV	binds	to	heparan	sulfate	on	the	host	surface	(Smit	et	al,	2002).	 An	 siRNA	 screen	 showed	 a	 reduction	 in	 the	 infection	 of	 IAV	 (a	 double-
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stranded	DNA	virus)	 followed	by	 the	 silencing	of	DDX31,	 but	 the	 investigators	did	not	pursue	this	result	any	further	(Diot	et	al,	2016)	and	DDX41	seems	to	have	a	role	in	innate	immunity	in	the	detection	of	double-stranded	DNA	viruses	(Jiang	
et	al,	2017).	As	SFV	and	VSV	are	RNA	viruses,	it	seems	that	virus-affecting	roles	of	DDX31	and	DDX41	might	 be	 exclusive	 to	DNA	viruses.	DDX43	has	not	 been	previously	 implicated	 in	 viral	 infection	 so	 it	 is	 not	 surprising	 that	 it	 does	 not	affect	SFV	or	VSV	infections.	Clathrin	has	been	thought	to	be	crucial	for	the	entry	of	both	SFV	and	VSV	(Helenius	et	al,	1980;	Sun	et	al,	2005),	but	according	to	my	results	the	entry	process	might	be	more	complicated,	and	CLTC	is	not	required	by	either	virus.	
	
5.5.	Methodological	considerations	As	siRNA-based	screening	has	become	cheaper	and	siRNA	design	has	improved,	a	number	of	large-scale	studies	on	host-virus	interactions	have	been	published	in	recent	 years	 (Perreira	 et	 al,	 2016).	 Even	 though	 siRNA-based	 screening	 is	definitely	a	powerful	tool,	 it	has	its	drawbacks.	Traditionally,	siRNAs	have	been	considered	very	specific	but	Franceschini	et	al	(2014)	showed	that	siRNAs	used	in	screening	can	act	as	micro-RNAs	(miRNAs)	and	have	strong	off-target	effects.	This	 kind	 of	 indirect	 effects	 may	 explain	 the	 surprising	 results	 of	 siRNA	treatments	against	TNP01,	RPL18,	and	ETF1	on	SFV	infection	as	well	as	those	of	siRNAs	against	PHB2	and	HDAC6	on	VSV	infection.	The	apparent	nonessentiality	of	 CLTC	 in	 both	 SFV	 and	 VSV	 infections	may	 also	 be	 explained	with	 off-target	effects.	It	may	also	be,	that	some	of	the	surprising	results	are	due	to	incomplete	knockdown	 of	 the	 studied	 host	 factors.	 Due	 to	 possibility	 of	 off-targets	 or	incomplete	 knockdown,	 the	 results	 of	 siRNA	 screens	 need	 to	 be	 extensively	validated.	 The	 knockdown	 efficiency	 of	 the	 siRNAs	 should	 be	 tested	 using	immunoblotting.	Preferably,	 the	roles	of	 the	genes	of	 interest	would	be	studied	using	 knockout	 cells.	 As	 an	 ultimate	 test,	 a	 rescue	 assay	 needs	 performed,	 in	which	knockdown	or	(preferably)	knockout	cells	are	transfected	with	a	plasmid	that	produces	 the	protein	 in	question.	This	 should	 lead	 to	 the	 reversion	of	 the	effect	 on	 virus	 infection.	 Due	 to	 the	 lack	 of	 further	 validation,	 the	 genes	implicated	by	my	experiments	are	to	be	understood	as	candidate	factors.			
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The	endocytic	bypass	assay	used	in	my	experiments	is	very	robust	and	separates	the	 function	 of	 the	 host	 factors	 to	 two	 rather	 broad	 categories.	 Therefore,	additional	 experiments	 are	 needed	 to	 perfectly	 understand	 the	 role	 of	 host	factors.	Using	confocal	microscopy,	it	is	possible	to	detect	if	viruses	bound	on	cell	surface	 are	 endocytosed	 or	 not	 (Rizopoulos	 et	 al,	 2015).	 To	 determine	 if	 the	depletion	 of	 the	 host	 factor	 affects	 SFV	 penetration	 or	 uncoating,	 specific	antibodies	 against	 the	 acidified	 spike	 proteins	 and	 SFV	 capsid	 proteins	 are	available	 (Liao	 &	 Kielian,	 2006)	 Spike	 acidification	 is	 a	 sign	 of	 membrane	penetration,	and	the	 localization	of	 the	signal	 from	anti-capsid	antibody	can	be	used	 to	 detect	 the	 uncoating	 events	 (Singh	&	Helenius,	 1992).	 To	pinpoint	 the	effects	 of	 host	 factors	 to	 later	 stages	 of	 SFV	 infection,	 immunoblotting	 can	 be	used	 to	detect	 the	production	of	early	and	 late	viral	proteins.	 Similarly	 to	SFV,	the	 endocytic	 part	 of	 VSV	 infection	 can	 be	 bypassed	 (Blumenthal	 et	al,	 1987).	Therefore,	performing	an	endocytic	bypass	assay	would	be	the	next	step	 in	the	elucidation	of	the	roles	of	the	host	factors	that	affect	VSV	infection,	followed	with	e.	g.	direct	measuring	of	VSV	endocytosis	(Rizopoulos	et	al,	2015).		
5.6.	Conclusions	The	major	 result	 of	 this	 study	 is	 that	 SLC6A13	 is	 a	 candidate	 receptor	 for	 SFV	and	 if	 validated,	 it	 implies	 that	 alphaviruses	 in	 general	use	 structurally	 similar	solute	carriers	as	their	receptors.	This	may	lead	to	the	discovery	of	the	receptors,	of	 other,	more	 clinically	 relevant	 alphaviruses,	which	 in	 turn	may	 lead	 to	 new	therapeutic	 applications.	 Overall,	 it	 is	 clear	 that	 multiple	 previously	uncharacterized	 host	 factors	 affect	 both	 SFV	 and	 VSV	 infections	 and	 many	 of	these	factors	are	specific	to	SFV	or	VSV.	This	thesis	also	shows	that	host	factors	play	 important	 parts	 in	 both	 the	 early	 and	 late	 stages	 of	 SFV	 infection.	 Taken	together,	the	results	of	this	thesis	further	confirm	that	virus-host	interactions	are	crucial	in	virus	infections.	My	findings	serve	as	a	starting	point	to	continue	to	in-depth	studies	into	how	these	factors	affect	SFV	and	VSV	infections.	
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Gene	symbol	 Gene	ID	 siRNA	sequences	 Gene	symbol	 Gene	ID	 siRNA	sequences	PHB2	 11331	 GUGAAUAUCUCCCUGCGAG	CCACAUCACAGAAUCGUAU	CAUCAAACUUCGCAAGAUU	CAGAAUAUCUCCAAGACGA		
DDX43	 55510		 CAACCAGAAUCAUUAGUCA	CGGCGAAGCUCGACAGUGU	CGCACAAUCUUAUUUGAAA	GAGAGGAAGGUUUGAAAUG	EDF1	 8721	 UAUCUUAGCGGCACAGAGA	UAACCAGGUGCUUGGCAAA	CAGAGGAGCUGCACCAUGA	CCACGAAAAUCAAUGAGAA		
DDX47	 51202		 GGAUGAAGCCGACCGAAUA	AGAAGAAACGCUCGCGAGA	UCAAAGUGAUUCCUCGAGA	CGAGUAGGUCGAACAGCUA		SLC6A13	 6540		 GCACAACCAGUAAUGGAGA	GGGCACUGGAACAACAAGA	AGAUCAUUGGCUUAGGCAA	AAACCAGUGUAUCCAGUCA		
DDX54	 79039		 GCACGAAAAUCCCGACAUA	CGUAAGAAGAAGCGGUUUG	GCAGAGGAGUUGCGGGUCU	UGGAAUACGUGGUGUUCGA		EIF2B3	 8891		 GAAAAUGGGUCAAUAACUU	AGACCUAACUUCCAGCAUU	GGUGGAGGAUCUCGGAUGA	GUUUAGAGCUUAUGAUGCA		
DHX37	 57647		 CGGAUGGUGUGCUGCUUAA	UCAAGAAACGCUACUACGA	GAAAUGCGGAAGUUUAAGA	CGACGACCCUGUCUUCAUC		ETF1	 2107	 GAGCUACGUUGGAAAUUGU	UAACUAUGUUCGGAAAGUA	AAACUGAACUAAGUCAAUC	AACAUUAAGUCACGAGUAA		
DHX57	 90957		 CAACAGACGUAGUAAUCGA	ACAAGUAGAUUCCGCAAAU	CUUCGGAACCUGUCGUAUA	UCACCAAGAACGAUGGAUA		EIF4G1	 1981	 GGGCUUAGCUGGAAGGAAU	GUUAAUGACCGAAGAUAUA	GGGAACAGAAGUAUGAAUA	GAUGUUAACAGAGGCAAUA		
KREMEN2	 79412		 CGGACUUCCCGGACGAGUA	GUCCAGGCCUGUCCGAAUG	CAACACAGCUACAGCAGCG	GAGCUCACCUUCCGCCUCU		DDX18	 8886		 GAUCUGAACGUCAACAGUA	CGGAUGACCCUAAGGAAUA	GAUAAUGGGUGGCAGUAAC	GAAGUCGACUGGAUUGUUC		
HDAC6		 10013	 GGGAGGUUCUUGUGAGAUC	GGAGGGUCCUUAUCGUAGA	GCAGUUAAAUGAAUUCCAU	GUUCACAGCCUAGAAUAUA		PVR	 5817		 GGAUCGGGAUUUAUUUCUA	CCAAACGGCUGGAAUUCGU	GGGCAUGUCUCCUAUUCAG	GCAAGAAUGUGACCUGCAA		
DNM2	 1785		 GGCCCUACGUAGCAAACUA	GAGAUCAGGUGGACACUCU	CCGAAUCAAUCGCAUCUUC	GAGCGAAUCGUCACCACUU		CSPG5	 10675		 CAGAUAUCAUUGACAUCGA	UCGAAGGACUGGAUGGUGA	GCGCAGAUCUGGGGAGCUU	CCUUGGAGGUUUGGCUGAA		
AP2M1	 1173		 GUUAAGCGGUCCAACAUUU	GCGAGAGGGUAUCAAGUAU	AGUUUGAGCUUAUGAGGUA	GAACCGAAGCUGAACUACA		GNPDA1	 10007		 GAGACCACCCGGAGAGUUA	GGAAUGCAGUCGACCUACA	CAGGUGGGAUCGAGCUAUU	UAUCACAGGUGCUCACAAG		
CLTC	 1213		 GAGAAUGGCUGUACGUAAU	UGAGAAAUGUAAUGCGAAU	GCAGAAGAAUCAACGUUAU	CGUAAGAAGGCUCGAGAGU		RPL18	 6141		 GGCUGUUGGUCAAGUUAUA	AGCCCAAGAGCCAGGAUAU	GAUCCUACUCUCUUAUUAA	UAACAAGGACCGAAAGGUU		
KPNB1	 3837		 GAACCAAGCUUGAUCUGUU	GCUCAAACCACUAGUUAUA	GACGAGAAGUCAAGAACUA	GGGCGGAGAUCGAAGACUA		UPF1	 5976		 CAGCGGAUCGUGUGAAGAA	CAAGGUCCCUGAUAAUUAU	GCAGCCACAUUGUAAAUCA	GCUCGCAGACUCUCACUUU		
TNPO1	 3842		 GCAAAGAUGUACUCGUAAG	GUAUAGAGAUGCAGCCUUA	GUAAAUACCAGCAUAAGAA	GCAAAUGUGUAUCGUGAUG		ATP6V1B2	 526		 CAGCUGAAUUUCUGGCGUA	GCACUUAUGUUUACGGAUA	UAUUCAAUGGAUCGGGAAA	GGGAGAAACGGCUCGAUUA		
Ppbi	 19035	 CAAGUUCCAUCGUGUCAUC	CGGCAAAGUUCUAGAGGGC	GGAGAAACCCUUCGCCAUU	GAAAGAGCAUCUAUGGUGA		ATP6V1G1	 9550	 CAUGAAAACUACCGCAUAA	CAGACAUACUUCCGGCAGA	AUUACUUGGUGUAUCGAUA	UUAGAUGCCCUCACGAAUA	
PPBI	 5479	 ACAGCAAAUUCCAUCGUGU	GAAAGAGCAUCUACGGUGA	GAAAGGAUUUGGCUACAAA	GGAAAGACUGUUCCAAAAA		DDX31	 64794	 CCAAAGAAGCAUUCGGUUA	CCGUACAGCUGGAGCCGUU	GCGAAACGGAGGAACGAAA	GCAAGCAAAGGCUACGAAA		
KIF11	 3832		 GAGCCCAGAUCAACCUUUA	GGAGAGGUCUAAAGUGGAA	UCGGGAAGCUGGAAAUAUA	GAAUAGGGUUACAGAGUUG		DDX41	 51428		 CUAAGGGCAUUACGUAUGA	GAACUAUGUACACCGGAUU	UAAAGCCUGUGACCAUCAA	CAACACCCAUUCAGAUCCA	
“scrambled”	 -	 UGGUUUACAUGUCGACUAA	UGGUUUACAUGUUGUGUGA	UGGUUUACAUGUUUUCUGA	UGGUUUACAUGUUUUCCUA	
	
